UPDATE: Roche's New Diabetes Drug Works Better Than Byetta

By Anita Greil Of DOW JONES NEWSWIRES Published at October 30, 2009 Views 158

Here's an article about taspoglutide and you don't have to subscribe to the WSJ to read it: ZURICH -(Dow Jones)- Roche Holding AG said Thursday its experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. in lowering blood sugar, according to the results of a late stage study. October 29, 2009: 08:19 AM ET

Read the full article at cnn.com

0

Likes

I like this I don't like this

Ask questions, get answers.
Give the community your two cents.
Be the first by adding your comments.